Entries by Mithra Pharmaceuticals

Mithra Announces 2020 Half Year Results

Substantial funding transactions of EUR 135 million that should secure Mithra for all future working capital needs, and more so if Estelle® receives marketing authorization Total revenues from licensing milestones for Estelle® of EUR 487 million, with EUR 349 million cash to still be collected (EUR 322 million under IFRS15) with a payment horizon dependent on the […]

Mithra to Host Webcast for Half Year Financial Results on 24 September 2020

Liege, Belgium, 21 September 2020 – 18:00  CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that it will host a live webcast on Thursday, 24 September 2020 at 15:00 CEST/ 09:00 EDT to announce its 2020 Half Year financial and operating results. The live webcast can be accessed on the Mithra website […]

Mithra’s EGM Approves Warrant Plan for Share Lending Shareholders

Liege, Belgium, 07 July 2020 – 17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that the Company’s Extraordinary General Meeting (EGM) held on 7 September 2020 approved the issuance of 300,000 warrants for the benefit of François Fornieri, Alychlo NV, and Noshaq SA (together the share lending shareholders), […]

Publication of a Transparency Notification Received from Alychlo NV

Liege, Belgium, 20 August 2020 – 17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that […]

Notice of Extraordinary Shareholders’ Meeting on 7th September 2020 Regarding Proposed Warrant Plans

Liège, Belgium, 7 August 2020 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces the publication of the invitation to its Extraordinary General Shareholders’ Meeting (EGM) that will be held on Monday September 7 2020 at 2:00 PM (CET) in Flémalle 57 rue de l’Expansion (Belgium).  

Information on the Total Number of Voting Rights (Denominator) Following the Completion of the LDA Capital Increase

Liege, Belgium, 05 August 2020 – 17:45 CEST –In accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, Mithra Pharmaceuticals SA (the “Company” or “Mithra”) announces the below information, following the […]

Mithra Announces Shelf Life Extension for Myring™ to 36 Months

Shelf life extended from 24 to 36 months in Europe Competitive advantage in terms of optimizing the supply chain costs and convenience for distributors, pharmacists and patients Liege, Belgium, 4 August 2020 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that the European Authorities have approved the […]

Mithra Signs LSA for Commercialization of Myring™ in France, Poland and United Kingdom

Mithra grants license to Zentiva for commercialization of its vaginal contraceptive ring in three key European markets Consolidation of commercial roll-out in Europe with 17 countries already under license Production ongoing at Mithra CDMO for upcoming European commercial launches Liege, Belgium, 06 July 2020 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated […]